10-Q Filing

TEVOGEN BIO HOLDINGS INC. CIK: 1860871 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001410578-22-001755`
Period End Date	20220331
Filing Date	20220517
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	lgstu-20220331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 42 Income Statement 6 Cash Flow Statement 12 Stockholders Equity 5

Balance Sheet 42 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$231.55K	USD	Point-in-time
Preferred stock, par value, (per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value, (per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$344.58K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$446.61K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$502.61K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$791.19K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$734.16K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses- non current	`PrepaidExpenseNoncurrent`	$38.95K	USD	Point-in-time
Prepaid expenses- non current	`PrepaidExpenseNoncurrent`	$145.17K	USD	Point-in-time
Cash and marketable securities held in Trust Account	`AssetsHeldInTrustNoncurrent`	$351.92M	USD	Point-in-time
Cash and marketable securities held in Trust Account	`AssetsHeldInTrustNoncurrent`	$352.06M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$352.83M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$352.85M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$129.00K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$39.38K	USD	Point-in-time
Due to affiliate	`DueToAffiliateCurrent`	$50.00K	USD	Point-in-time
Due to affiliate	`DueToAffiliateCurrent`	$20.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$179.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$59.38K	USD	Point-in-time
Derivative warrant liabilities	`SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares`	$304.50K	USD	Point-in-time
Derivative warrant liabilities	`SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares`	$420.50K	USD	Point-in-time
Deferred underwriting fee payable	`DeferredOfferingCostsNoncurrent`	$14.70M	USD	Point-in-time
Deferred underwriting fee payable	`DeferredOfferingCostsNoncurrent`	$14.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.18M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.18M	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-14.23M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-14.26M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquity`	$-14.23M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquity`	$-14.25M	USD	Point-in-time
TOTAL LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$352.85M	USD	Point-in-time
TOTAL LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$352.83M	USD	Point-in-time

Income Statement 6 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$282.88K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$282.88K	USD	1 Quarter
Unrealized gain on investments held in Trust Account	`UnrealizedGainLossOnInvestments`	$140.89K	USD	1 Quarter
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$-116.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$256.89K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-25.99K	USD	1 Quarter

Cash Flow Statement 12 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-25.99K	USD	1 Quarter
Unrealized gain on investments held in Trust Account	`UnrealizedGainLossOnInvestments`	$140.89K	USD	1 Quarter
Change in the fair value of warrants	`FairValueAdjustmentOfWarrants`	$-116.00K	USD	1 Quarter
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-50.22K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$89.62K	USD	1 Quarter
Due to affiliate	`IncreaseDecreaseInDueToAffiliatesCurrent`	$30.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-113.03K	USD	1 Quarter
NET CHANGE IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-113.03K	USD	1 Quarter
CASH, BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$344.58K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.55K	USD	Point-in-time
CASH, END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$344.58K	USD	Point-in-time
CASH, END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.55K	USD	Point-in-time

Stockholders Equity 5 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning	`StockholdersEquity`	$-14.23M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$-14.25M	USD	Point-in-time
NET LOSS	`NetIncomeLoss`	$-25.99K	USD	1 Quarter
Balance at the end	`StockholdersEquity`	$-14.23M	USD	Point-in-time
Balance at the end	`StockholdersEquity`	$-14.25M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.